Protecting your IP
We have one of the most renowned life sciences practices in the UK. We help leading companies to commercialise their technology and scientific discoveries. Our life sciences practice helps companies bring more innovative drugs, therapies and devices to the market, enabling people to live longer and healthier lives.
Our dedicated life sciences team has extensive experience advising entrepreneurs, investors, and technology companies, operating in a range of sectors, including biotech, med-tech, food tech and health-tech (including digital health).
From inception to exit, we are familiar with the life cycle of life sciences companies and the demands on scaling your business. From structuring and fundraising for early stage companies to M&A and IPO for later stage companies.
Our renowned charities team advises some of the leading charities in healthcare and research. We advise charities on governance and structuring issues where research is funded through charitable grants, social and financial investments. The team also advises organisations receiving charitable funding or investment.
Technology transfers & spin-outs
Our team has a successful record of transferring technology and launching spin-out companies from notable universities, research institutions and tech accelerators. Our experience includes advising on investment and shareholder rights, and drafting and negotiating licensing documents and technology transfer agreements, including technology access through pipeline agreements, options and rights of first refusal.
For organisations whose business is simply growing beyond their existing legal capacity or which do not yet have budget for full time in-house lawyer, we offer general counsel support, whether at project specific fees and/or on a fixed monthly budget to meet your needs.
For further help or informationGet in touch
InsightView all Firm insight
28 January 2020 - Article
SNAP: The stretch just broke – Time to revisit IRA and Qualified Plan Beneficiary Designations
27 January 2020 - Article
UK residential property for the foreign investor in 2020 – a window of opportunity?
24 January 2020 - Article
EB-5 in 2020: Managing the 'Stun Gun' that just hit the investment program
Would you like to hear more from us?
Visit our subscriptions page to tell us a bit more about what you’re interested in so we can send you relevant news.